43975-315 : Bexarotene 75 mg Oral Capsule, Liquid Filled

Labeler: Amerigen Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Bexarotene
Dosage Form: Oral Capsule, Liquid Filled
Application #: ANDA209861
Rev. Date: 


Markings: A78
Shapes:  Capsule
Colors:  White
Size (mm): 20
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 43975-315-10: 100 CAPSULE, LIQUID FILLED IN 1 BOTTLE (43975‑315‑10)

Active Ingredients:

  • Bexarotene

Dosage Strength:

  • 75 mg

Inactive Ingredients:

  • Butylated Hydroxyanisole
  • Glycerin
  • Medium-chain Triglycerides
  • Nitrogen
  • Polyethylene Glycol 400
  • Polysorbate 20
  • Povidone K90
  • Propylene Glycol
  • Sorbitol
  • Lecithin, Soybean
  • Shellac
  • Fd&c Red No. 40
  • Fd&c Blue No. 1
  • Fd&c Yellow No. 6
  • Dimethiconol/Trimethylsiloxysilicate Crosspolymer (40/60 W/W
  • 1000000 Pa.s)
  • Titanium Dioxide
  • Mannitol
  • 1,4-sorbitan
  • Gelatin Hydrolysate (Porcine Skin, Mw 3000) /

Pharmaceutical Classes:

  • Retinoid [EPC]
  • Retinoids [CS]

Related Products:

Based on records with the same trade name.
  • 0054-0399 Bexarotene 75 mg Oral Capsule, Liquid Filled by Hikma Pharmaceuticals USA Inc.
  • 0378-6955 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Pharmaceuticals Inc.
  • 0591-2832 Bexarotene 75 mg Oral Capsule, Liquid Filled by Actavis Pharma, Inc.
  • 0832-0285 Bexarotene 75 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 42292-007 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Institutional Inc.
  • 68682-002 Bexarotene 1 g/100g Topical Gel by Oceanside Pharmaceuticals
  • 68682-003 Bexarotene 75 mg Oral Capsule, Liquid Filled by Oceanside Pharmaceuticals
  • 69238-1250 Bexarotene 75 mg Oral Capsule by Amneal Pharmaceuticals LLC
  • 69238-2088 Bexarotene 10 mg/g Topical Gel by Amneal Pharmaceuticals Ny LLC


Scan the QR code below to easily reference this data in the future:

NDC 43975-315 QR Code

< Prev: 43975-310Next: 43975-322 >

Related Discussions:

Bexarotene for Alzheimer's
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.